Evaluation of omega-3 supplementation intake on the risk of preeclampsia
Phase 3
Completed
- Conditions
- Pre-eclampsia.Pre-eclampsia
- Registration Number
- IRCT20180103038196N4
- Lead Sponsor
- Gorgan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Female
- Target Recruitment
- 122
Inclusion Criteria
nulliparous Pregnant women with 14 to 18 weeks gestational age
Satisfaction to participate in the study
Women without a high risk of preeclampsia (age under 20 and over 40 years, history of preeclampsia in a previous pregnancy or in the family, twins pregnancy, body mass index equal or greater than 29, kidney disease and hypertension )
Do not use calcium, aspirin, anticoagulants and insulin
No history of allergy to omega-3
20 to 40 years old
Exclusion Criteria
Unwillingness to cooperate
Forced to use aspirin, calcium and heparin during the study
Not being able to continue taking medication due to digestive problems or because of an allergic reaction
Women with a high risk of preeclampsia
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Pre-eclampsia Prevalence in Nulliparous Pregnant Women. Timepoint: From the beginning of the study to the end of pregnancy. Method of measurement: Pressure gauge and criteria for diagnosis of pre-eclampsia.
- Secondary Outcome Measures
Name Time Method